valganciclovir

Viracta lays off 23% of staff, pauses program to slim down for race to finish line in lymphoma
Fierce Biotech
Wed, 08/14/24 - 11:18 am
Viracta Therapeutics
layoffs
solid tumors
valganciclovir
peripheral T-cell lymphoma
Roche adds HIV blindness drug to patent pool, cutting price
Reuters
Mon, 08/5/13 - 07:27 am
Roche
patents
HIV blindness
Medicines Patent Pool
valganciclovir